Scotland is to have its own £15.8m artificial intelligence health research centre, which promises to enable better patient diagnosis, treatment and outcomes. The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics, to be known as iCAIRD, brings together a pan-Scotland collaboration of 15 partners from across academia, the NHS, and industry. Greg Clark, UK Secretary of State for Business, Energy and Industrial Strategy (BEIS), announced that UK Research and Innovation will invest £10million in iCAIRD...
Absolute Antibody Ltd., specialists in antibody sequencing, engineering and recombinant expression with a vision to make recombinant antibody technology accessible to all, has announced the opening of a new facility in northeast England. The new facility more than doubles Absolute Antibody’s laboratory space and will enable an even greater increase in its antibody production capacity, allowing the company to better service customers and accelerate the expansion of its recombinant antibody portfolio....
DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes. Broad Institute CRISPR-Cas9 technology will be combined with DefiniGEN’s best-in-class induced Pluripotent Stem Cell (iPSC) differentiation platform to generate preclinical cell models which can accelerate....
Provepharm Life Solutions and partner Walter Reed Army Institute of Research were selected for project focusing on anti-malaria treatment in endemic regions. Provepharm Life Solutions, a French independent pharmaceutical and life sciences group which revitalizes known molecules, announces today it has won the 2018 Prix Galien-Medstartup Award. The company was selected or its collaborative project with the Experimental Therapeutics branch (ET), Medical Research Directorate, Africa (MRD-A), and the Armed Forces Research Institute of Medical Sciences....
Platform Patent for Clustering a Subset of Antigens for Diagnosing Diseases. ImmunArray, a molecular diagnostic company co-headquartered in Rehovot, Israel and Richmond, Virginia, whose novel blood tests are pioneering new and more accurate ways to diagnose diseases detected by changes in the immune system, has announced that the U.S. Patent and Trademark Office (USPTO) recently issued a new patent that covers one of ImmunArray’s core diagnostic protocols – generic methods....
The words of Nobel laureate Sydney Brenner, “Progress in science depends on new techniques, new discoveries and new ideas, probably in that order”, could not be more truefor gene editing. Here, Maya Raghunandan, freelancer for online platform for freelance scientists Kolabtree and molecular biologist, explains some key applications of gene editing and its ethical implications. Gene editing applications span various industries, most notably food and healthcare. It refers to specific, intentional alterations to the DNA sequence of a cell, tissue or organism....
Accelerated Technology Laboratories, Inc., a leader in Laboratory Information Management Systems (LIMS), continues the 2018 LIMS Webcast series on Wednesday, November 14th with Automating Cannabis Testing with LIMS.This webcast will provide valuable guidance for organizations looking to select and implement a LIMS to help manage their cannabis testing operations. With the legalization of cannabis for both medical and recreational uses within several states in the US, and recently in Canada, the need for analytical testing laboratories has grown significantly....
The biocluster located in the Greater Paris region is the first European park to receive the Association of University Research Parks (AURP) award. Genopole, a French biocluster dedicated to research in the fields of genetics and biotechnology, today announces it has received the AURP Award of Excellence for Outstanding Research Park. This is the first time a member outside the US has been acknowledged. The announcement was made during AURP’s International Annual Conference in Baltimore (Maryland)...
Technology supported by Dr Jonathan Milner in his ELRIG Plenary Address. Elpis Biomed Ltd., a University of Cambridge spin-out developing high quality human cells via its proprietary OPTi-OX platform, is pleased to announce that life science entrepreneur Dr Jonathan Milner, Deputy Chairman and Founder of Abcam, mentioned the Company, stating: “Elpis human cells can fix the broken drug discovery process by replacing animal experiments,” during his plenary lecture at the recent ELRIG Drug Discovery Conference....
University of Leicester researchers have developed a computer system to scan large sets of genomes in deadly pathogens. Innovative computer software developed by University of Leicester scientists is shedding new light on the genetic makeup of deadly pathogens responsible for meningitis and gastroenteritis. The software, called ‘PhasomeIt’, rapidly scans through large sets of genomes and identifies their phase variable genes, whilst also comparing all of these genes against one another....
Electric fields destroy listeria without damaging nutrients. Team from the University of Natural Resources and Life Sciences, Vienna, identifies conditions for inactivating Listeria while maintaining product quality during the processing of whey proteins. Low temperatures and an acidic environment create the ideal conditions for applying an effective method of inactivating Listeria (and other germs) in the processing of whey proteins...
Launch of novel, high throughput in vitro platform will help researchers find molecules that can prevent prion-like spreading of neurodegenerative disease associated peptides. Cellectricon AB, a collaborative research organization dedicated to advancing drug discovery and research in the areas of chronic pain and CNS diseases, announce the launch of a novel assay platform for in vitro neurodegenerative disease research. The platform, based on a patent-pending microfluidics technology, has been developed over the past two years...
Asynt report on how installation of a Liquid Nitrogen generator at the Scottish Association for Marine Science (SAMS) is helping the organisation improve long term cryostorage of their precious samples in an environmentally friendly manner. The Scottish Association for Marine Science (SAMS) is Scotland's premier independent marine science organisation generating new knowledge for the benefit of the marine environment and society since 1884. Scientists at the SAMS Institute study how the marine environment works....
MediSieve wins 1st runner up at prestigious Boston Biotech Week start up competition. Medical device company, MediSieve, received accolades for their ground breaking work during the Biotech Week held in Boston in September 2018. MediSieve won first runner up for Best Business Plan at the Xcelerate Startup Pitch Competition hosted by Xcelerate Insight and EBD Group. The pitch competition is designed to give early stage companies exposure to possible investors and partners...
Join us for the day on 4 December 2018 at Schauenburg Analytics, Offenbach am Main, Germany, for a free-to-attend workshop, and learn about the recent advances in VOC and SVOC sampling and analysis for GC–MS. You’ll also have an opportunity to have a look around the laboratory and get hands-on with the instrumentation. What you'll learn...
A collaboration between Watson-Marlow Fluid Technology Group (WMFTG) and a leading American training institute is helping to deliver first-class learning experiences for the bioprocessing sector. The Golden LEAF Biomanufacturing Training and Education Center (BTEC) in North Carolina, USA is now equipped with WMFTG’s Quantum pump technology: thereby offering users and trainees access to the latest in pump innovation in bioprocessing...
Creative Medical Research is working with a medical device manufacturer to find Lab Managers, Lab Technicians and Pathologists to take part in 60 minute face-to-face interviews in London and Manchester. The research relates to a new blood analysis device for lab settings and the interviews are required as part of the regulatory approval process. Not only will your involvement help the client move towards approval, it will also give you an opportunity to influence the final design of the device, ensuring it is fit for purposes and optimised from the user’s perspective....
Science communication refers to the process of effectively relaying the facts and findings from scientific studies to other scientists, non-experts and the general public. This helps people understand broader implications of scientific studies for society. Here, Maya Raghunandan, freelancer for online platform for freelance scientists Kolabtree and molecular biologist, explains how scientists can help with effective science communication.....
Raremark, the leading patient-data platform in rare disease, has raised £3m in funding from investors, led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund. The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments....
Again and again consumers are confronted with scandals in the foodstuff industry. The latest case is the Fipronil egg scandal in the laying hen farming in the Netherlands and in Lower Saxony (Germany). What actually do foodstuff producers and marketers do to avoid such cases? A lot, if you believe the rising costs in the area of modern foodstuff analysis. So during the last decades, always newer and more sophisticated processes will be and were developed with the most sensitive detection thresholds (ELISA, PCR or the mycotoxin analysis) for quality control...
Thermo Fisher and Symphogen to develop new workflows to characterize and monitor the quality of mixed antibody products. Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused company, have entered into a two-year collaborative partnership to deliver validated, platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins.....
Ferring Accesses Evotec's Integrated Small Molecule Discovery and Development Platform to Progress New Molecules from Concept to Potential Drug Candidates. Evotec is Eligible for Undiscovered Research Funding and Milestones. Evotec AG and Ferring Pharmaceuticals ("Ferring") has announced a strategic research alliance to discover and develop new small molecule therapies to treat patients living with fertility and gynaecological conditions...
Scotland is to have its own £15.8m artificial intelligence health research centre, which promises to enable better patient diagnosis, treatment and outcomes. The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics, to be known as iCAIRD, brings together a pan-Scotland collaboration of 15 partners from across academia, the NHS, and industry. Greg Clark, UK Secretary of State for Business, Energy and Industrial Strategy (BEIS), announced that UK Research and Innovation will invest £10million in iCAIRD...
Absolute Antibody Ltd., specialists in antibody sequencing, engineering and recombinant expression with a vision to make recombinant antibody technology accessible to all, has announced the opening of a new facility in northeast England. The new facility more than doubles Absolute Antibody’s laboratory space and will enable an even greater increase in its antibody production capacity, allowing the company to better service customers and accelerate the expansion of its recombinant antibody portfolio....
DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes. Broad Institute CRISPR-Cas9 technology will be combined with DefiniGEN’s best-in-class induced Pluripotent Stem Cell (iPSC) differentiation platform to generate preclinical cell models which can accelerate....
Provepharm Life Solutions and partner Walter Reed Army Institute of Research were selected for project focusing on anti-malaria treatment in endemic regions. Provepharm Life Solutions, a French independent pharmaceutical and life sciences group which revitalizes known molecules, announces today it has won the 2018 Prix Galien-Medstartup Award. The company was selected or its collaborative project with the Experimental Therapeutics branch (ET), Medical Research Directorate, Africa (MRD-A), and the Armed Forces Research Institute of Medical Sciences....
Platform Patent for Clustering a Subset of Antigens for Diagnosing Diseases. ImmunArray, a molecular diagnostic company co-headquartered in Rehovot, Israel and Richmond, Virginia, whose novel blood tests are pioneering new and more accurate ways to diagnose diseases detected by changes in the immune system, has announced that the U.S. Patent and Trademark Office (USPTO) recently issued a new patent that covers one of ImmunArray’s core diagnostic protocols – generic methods....
The words of Nobel laureate Sydney Brenner, “Progress in science depends on new techniques, new discoveries and new ideas, probably in that order”, could not be more truefor gene editing. Here, Maya Raghunandan, freelancer for online platform for freelance scientists Kolabtree and molecular biologist, explains some key applications of gene editing and its ethical implications. Gene editing applications span various industries, most notably food and healthcare. It refers to specific, intentional alterations to the DNA sequence of a cell, tissue or organism....
Accelerated Technology Laboratories, Inc., a leader in Laboratory Information Management Systems (LIMS), continues the 2018 LIMS Webcast series on Wednesday, November 14th with Automating Cannabis Testing with LIMS.This webcast will provide valuable guidance for organizations looking to select and implement a LIMS to help manage their cannabis testing operations. With the legalization of cannabis for both medical and recreational uses within several states in the US, and recently in Canada, the need for analytical testing laboratories has grown significantly....
The biocluster located in the Greater Paris region is the first European park to receive the Association of University Research Parks (AURP) award. Genopole, a French biocluster dedicated to research in the fields of genetics and biotechnology, today announces it has received the AURP Award of Excellence for Outstanding Research Park. This is the first time a member outside the US has been acknowledged. The announcement was made during AURP’s International Annual Conference in Baltimore (Maryland)...
Technology supported by Dr Jonathan Milner in his ELRIG Plenary Address. Elpis Biomed Ltd., a University of Cambridge spin-out developing high quality human cells via its proprietary OPTi-OX platform, is pleased to announce that life science entrepreneur Dr Jonathan Milner, Deputy Chairman and Founder of Abcam, mentioned the Company, stating: “Elpis human cells can fix the broken drug discovery process by replacing animal experiments,” during his plenary lecture at the recent ELRIG Drug Discovery Conference....
University of Leicester researchers have developed a computer system to scan large sets of genomes in deadly pathogens. Innovative computer software developed by University of Leicester scientists is shedding new light on the genetic makeup of deadly pathogens responsible for meningitis and gastroenteritis. The software, called ‘PhasomeIt’, rapidly scans through large sets of genomes and identifies their phase variable genes, whilst also comparing all of these genes against one another....
Electric fields destroy listeria without damaging nutrients. Team from the University of Natural Resources and Life Sciences, Vienna, identifies conditions for inactivating Listeria while maintaining product quality during the processing of whey proteins. Low temperatures and an acidic environment create the ideal conditions for applying an effective method of inactivating Listeria (and other germs) in the processing of whey proteins...
Launch of novel, high throughput in vitro platform will help researchers find molecules that can prevent prion-like spreading of 
Asynt report on how installation of a Liquid Nitrogen generator at the Scottish Association for Marine Science (SAMS) is helping the organisation improve long term cryostorage of their precious samples in an environmentally friendly manner. The Scottish Association for Marine Science (SAMS) is Scotland's premier independent marine science organisation generating new knowledge for the benefit of the marine environment and society since 1884. Scientists at the SAMS Institute study how the marine environment works....
MediSieve wins 1st runner up at prestigious Boston Biotech Week start up competition. Medical device company, MediSieve, received accolades for their ground breaking work during the Biotech Week held in Boston in September 2018. MediSieve won first runner up for Best Business Plan at the Xcelerate Startup Pitch Competition hosted by Xcelerate Insight and EBD Group. The pitch competition is designed to give early stage companies exposure to possible investors and partners...
Join us for the day on 4 December 2018 at Schauenburg Analytics, Offenbach am Main, Germany, for a free-to-attend workshop, and learn about the recent advances in VOC and SVOC sampling and analysis for GC–MS. You’ll also have an opportunity to have a look around the laboratory and get hands-on with the instrumentation. What you'll learn...
A collaboration between Watson-Marlow Fluid Technology Group (WMFTG) and a leading American training institute is helping to deliver first-class learning experiences for the bioprocessing sector. The Golden LEAF Biomanufacturing Training and Education Center (BTEC) in North Carolina, USA is now equipped with WMFTG’s Quantum pump technology: thereby offering users and trainees access to the latest in pump innovation in bioprocessing...
Creative Medical Research is working with a medical device manufacturer to find Lab Managers, Lab Technicians and Pathologists to take part in 60 minute face-to-face interviews in London and Manchester. The research relates to a new blood analysis device for lab settings and the interviews are required as part of the regulatory approval process. Not only will your involvement help the client move towards approval, it will also give you an opportunity to influence the final design of the device, ensuring it is fit for purposes and optimised from the user’s perspective....
Science communication refers to the process of effectively relaying the facts and findings from scientific studies to other scientists, non-experts and the general public. This helps people understand broader implications of scientific studies for society. Here, Maya Raghunandan, freelancer for online platform for freelance scientists Kolabtree and molecular biologist, explains how scientists can help with effective science communication.....
Raremark, the leading patient-data platform in rare disease, has raised £3m in funding from investors, led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund. The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments....
Again and again consumers are confronted with scandals in the foodstuff industry. The latest case is the Fipronil egg scandal in the laying hen farming in the Netherlands and in Lower Saxony (Germany). What actually do foodstuff producers and marketers do to avoid such cases? A lot, if you believe the rising costs in the area of modern foodstuff analysis. So during the last decades, always newer and more sophisticated processes will be and were developed with the most sensitive detection thresholds (ELISA, PCR or the mycotoxin analysis) for quality control...
Thermo Fisher and Symphogen to develop new workflows to characterize and monitor the quality of mixed antibody products. Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused company, have entered into a two-year collaborative partnership to deliver validated, platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins.....
Ferring Accesses Evotec's Integrated Small Molecule Discovery and Development Platform to Progress New Molecules from Concept to Potential Drug Candidates. Evotec is Eligible for Undiscovered Research Funding and Milestones. Evotec AG and Ferring Pharmaceuticals ("Ferring") has announced a strategic research alliance to discover and develop new small molecule therapies to treat patients living with fertility and gynaecological conditions...